MarketGrader China New Elite 30 Index


Five Largest Companies (Top 5 of 29)

Five Smallest Companies (Top 5 of 1)

Companies with Most Selections Among Current Components
*Number of times selected at Index semi-annual reconstitutions since inception date.
Index Bio
Average Market Cap $33,095.21
Median Market Cap $9,039.73
Avg. 3 Mo. Dollar Vol. $139,224,073.95
Avg. 3 Mo. Trading Vol. 17,193,129
Last Rebalance Date 06/15/2020
Companies Replaced 15
Biggest Industry Increase Consumer Staples
Biggest Industry Decrease Biotechnology

Fundamental Attributes
Trailing P/E Ratio (12 Mo.) 25.96
Forward P/E Ratio (12 Mo.) 27.57
Price/Book Ratio 6.41
Avg. Revenue Chg. - 3 Yr 62.26%
Avg. Op. Income Chg. - 3 Yr. 84.12%
Avg. EPS Growth - 3 Yr. 16.86%
Avg. EPS Growth - 1 Yr. 20.11%
Avg. Operating Margin 25.42%
Avg. LT Debt to Total Capital 14.07%
Avg. Return on Equity 22.77%
Dividend Yield 1.54%
Index Average Grade
MarketGrader China New Elite 30 Index 63.09
Country Breakdown
China 100.0%


For more information on this index please contact us

REQUEST TRIAL NOW